(VIANEWS) – Shares of Xenetic Biosciences (XBIO) rose 8.66% to $3.83 at 10:31 EST on Wednesday, following the last session’s downward trend. NASDAQ Composite is jumping 0.03% to $14,765.49, after two consecutive sessions in a row of gains. This seems, up until now, a somewhat up trend trading session today.
Xenetic Biosciences’s last close was $4.07, 30.43% below its 52-week high of $5.85.
Today’s last reported volume for Xenetic Biosciences is 2241888 which is 75.3% below its average volume of 9077212.
The company’s growth estimates for the current quarter is a negative 6.7% and positive 85% for the next.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.
Xenetic Biosciences’s last week, last month’s, and last quarter’s current volatility was 8.71%, 1.07%, and 4.79%, respectively.
Xenetic Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.71% (last week), 6.66% (last month), and 4.79% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be overbought (>=80).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $3.83 at 10:31 EST, way under its 52-week high of $5.85 and way above its 52-week low of $0.76.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s value is way above its 50-day moving average of $2.29 and way above its 200-day moving average of $2.32.
More news about Xenetic Biosciences (XBIO).